Tranexamic acid decreases risk of haematomas but not pain after hip arthroplasty.

BACKGROUND: Tranexamic acid decreases total blood loss after total hip arthroplasty (THA). Total blood loss is the sum of external bleeding and bleeding into tissues, i.e., haematomas. Haematomas may cause acute or even chronic postoperative pain. HYPOTHESIS: Tranexamic acid decreases haematomas, thereby diminishing postoperative pain after THA. METHODS: In a retrospective matched case-control study, patients receiving tranexamic acid (15 mg/kg, before the incision and again at skin closure) were compared to controls not given tranexamic acid. Matching was on sex, surgeon, and peri-operative analgesics (ketamine, ketoprofen, pregabalin, and nefopam). Standardised protocols were used for anaesthesia, analgesia, and blood sparing. Haematoma volume was computed as the difference between total blood loss (estimated from the erythrocyte counts on days -1 and +5) and measured external blood loss. Patients were monitored from D0 to D7 then interviewed by telephone on D30, D90, and D180. To detect a 30%-decrease in the morphine dose at H24 (criterion 1) and D7 (criterion 2) and a 20% decrease in haematoma volume on D5 (criterion 3), the required numbers of patients were 90, 90, and 77, respectively; therefore, 95 patients were included. RESULTS: Tranexamic acid decreased haematoma volume by 30% (351±254 mL versus 247±189 mL erythrocytes, P=0.002), had no effect on morphine consumption at H24 (12±11 mg versus 14±12 mg, P=0.346), increased morphine consumption on D7 (26±24 mg versus 35±36 mg, P=0.029), and had no effect on long-term pain. DISCUSSION: After THA, tranexamic acid decreases haematoma volume without improving analgesia. LEVEL OF EVIDENCE: 3 (case-control study).

[Tolerance and efficacy of peripheral nerve blocks for carpal tunnel release]. / Tolérance et efficacité des blocs nerveux périphériques pour la chirurgie du canal carpien.

INTRODUCTION: Several peripheral nerve block techniques (PNB) are performed for hand surgery. Their tolerance by patients or their efficacy are poorly described. We evaluated them for blocks at the wrist and at the brachial canal. PATIENTS AND METHODS: Cohort of outpatients undergoing open carpal tunnel release under PNB with arm tourniquet. Various anaesthetic protocols existed in our staff. The primary end points were a moderate to severe pain (greater than 3/10 on a numerical rating scale) felt during needle puncture, nerve stimulation, mepivacaine injection, at the surgical site (intraoperatively) or at the arm tourniquet, an intraoperative lidocaine supplementation, the occurrence of vasovagal events. For each primary end point, a logistic regression analyzed: the effects of gender, age, operated side, Emla(®)application, sedation before PNB (midazolam-sufentanil), wrist or brachial canal approach, musculocutaneous or radial block were using. RESULTS: Between January 2007 and June 2010, 551 consecutive patients were analyzed. Puncture pain, mepivacaine injection pain, pain tourniquet and vasovagal events were associated with wrist block (P=0.003, relative risk=1.86; P<0.001, RR=4.22; P<0.001, RR=4.52; P=0.035, RR=6.40). An intraoperative pain greater than 3/10 at the surgical site, or a supplementation by the surgeon were associated with the absence of musculocutaneous block (P=0.013, RR=2.44; P=0.013, RR=2.51). DISCUSSION: Wrist blocks are less tolerated than brachial canal blocks. The musculocutaneous nerve might often participate in the palm sensitive innervation. For open carpal tunnel release, median, ulnar and musculocutaneous nerves blocks at the brachial canal should be preferred.

[Benefits and safety of perioperative pregabalin: a systematic review]. / Balance bénéfique risque de la prégabaline en périopératoire : revue systématique de la littérature.

OBJECTIVE: Perioperative gabapentine administration improves analgesia, reduces postoperative nausea and vomiting, but increases sedation. Pregabalin is also a gabapentinoid, with an improved bioavailability. This systematic review evaluates the analgesic effect and tolerance of perioperative pregabaline. STUDY DESIGN: Systematic review. METHODS: Systematic search in Pubmed database of clinical human randomized controlled studies dealing with perioperative administration of pregabalin. A quantitative review of pregabalin efficiency and an analysis of the main side effects reported in these studies was then performed. RESULTS: Twenty-three study arms (884 patients) received at least one dose of pregabalin in 17 studies (totalizing 1577 patients). Pregabalin improved analgesia in 11 of 23 study arms. Pregabalin improved analgesia in three of 12 study arms after ambulatory surgery, and in eight of 11 after major surgery (P=0.04). Two of three studies about chronic postoperative pain revealed improved results in pregabalin groups. Nevertheless, pregabalin did not reduce postoperative nausea/vomiting, pruritus and headache, but increased trouble with vision, drowsiness, severe sedation and dizziness during the first postoperative hours, without severe clinical consequence. Severe sedation seemed clearly dose dependant, while drowsiness, dizziness or visual disturbance did not. CONCLUSION: A favorable benefit risk-ratio is demonstrated only for major surgery (excluding ambulatory surgery). The lack of data concerning tolerance of pregabalin in the elderly and/or in case of renal dysfunction forbids any conclusion in these populations.

[Tranexamic acid reduces haematomas but not pain after total knee arthroplasty]. / L'acide tranexamique diminue les hématomes mais pas les douleurs après prothèse totale de genou.

AIM: Tranexamic acid (TxA) reduces total blood losses (TBL) and allogenic transfusion (TH) after total knee arthroplasty (TKA). TBL can be external (surgical field, drains), or hidden (haematomas). Haematomas induce pain and limit postoperative rehabilitation. The aim of the study was to evaluate if TxA reduces haematomas and pain after TKA. STUDY DESIGN: Prospective non-randomized study. METHOD: After ethical committee approvement and written informed consent, the patients planned for a primary TKA were included (control group followed by a TxA group, 15 mg/kg before incision and at skin closure). General anaesthesia and analgesia were standardized (sciatic block, continuous femoral block, ketamine, ketoprofene, paracetamol, PCA with morphine). Volume of haematomas=TBL (calculated based on haemograms performed the day before surgery, and at postoperative day 5, and on transfusions)-measured external bleeding. Patients were followed up for 8 days, and at postoperative day 180 (by phone). Fifty patients per group allowed the detection of a 50% morphine sparing at day 8 (α=0.05 and ß=0.2), and a 25% reduction of haematoma volumes at day 5. RESULTS: Perioperative data, pain scores and functional parameters (until day 180) were not different between control group patients (n=52) and TxA group patients (n=55): morphine consumption at day 8 was respectively 35 ± 32 and 42 ± 38 mg (P=0.29). Yet, TxA reduced hematoma volumes (526 ± 202 versus 337 ± 165 mL of red blood cells, P<0.0001) and clinically apparent hematomas. Morphine consumptions at day 8 and haematoma volumes were not correlated. CONCLUSION: After TKA, TxA reduces the volume of hematomas, without any improvement in analgesia and rehabilitation until the sixth postoperative month.

[Delayed autologous transfusion in prosthetic surgery of the hip and knee]. / Transfusion autologue différée pour la chirurgie prothétique de la hanche et du genou.

Blood sparing methods used during hip or knee prosthesis implantation or change in 360 patients during the years 1990-1992 were evaluated. For delayed transfusion of autologous blood the main counter-indication was unstable cardiovascular condition. Such cases being excluded, the method was used in 64.2% of all cases. No homologous blood was needed in 68.9% of patients. This result was obtained in 55% of the cases by delayed transfusion of autologous blood and in 13.9% by peroperative normovolaemic haemodilution.

[Consumption coagulopathy and meningioma]. / Coagulopathie de consommation et méningiome.

A twenty year old man died after coagulation disorders following neurosurgery. Disseminated intravascular coagulation and fibrinolysis occurring after neurosurgery of brain tumours are discussed.